BioRestorative Therapies, Inc. Sustainability Profile
BioRestorative Therapies, Inc., headquartered in the United States, is a pioneering company in the regenerative medicine industry. Founded in 2008, the firm focuses on developing innovative therapies that harness the power of stem cells and other biological materials to treat various medical conditions. With a strong emphasis on research and development, BioRestorative Therapies has made significant strides in areas such as obesity, chronic pain, and spinal disc disease. Their core offerings include proprietary stem cell-based treatments that stand out for their potential to promote healing and restore function. Recognised for its commitment to advancing medical science, BioRestorative Therapies has positioned itself as a leader in the regenerative medicine market, continually striving to improve patient outcomes through cutting-edge solutions.
DitchCarbon Score
How does BioRestorative Therapies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BioRestorative Therapies, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BioRestorative Therapies, Inc.'s reported carbon emissions
BioRestorative Therapies, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that BioRestorative Therapies may not yet have established a comprehensive framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing measurable targets and strategies to align with global climate goals.
How Carbon Intensive is BioRestorative Therapies, Inc.'s Industry?
How Carbon Intensive is BioRestorative Therapies, Inc.'s Location?
BioRestorative Therapies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BioRestorative Therapies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
